Here's Why Telix Pharmaceuticals (ASX:TLX) Can Manage Its Debt Responsibly
May 15
Have your own idea? Try our Stock Screener
Australian (ASX) Biotech Industry Analysis
UpdatedMay 24, 2025
DataAggregated Company Financials
Companies31
- 7D1.4%
- 3M-6.5%
- 1Y-9.1%
- YTDn/a
The Biotech industry is up 2.9% in the last week, with CSL up 1.9%. In the past year, the industry is down 9.4%. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Australian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 24 May 2025 | AU$133.4b | AU$24.6b | AU$3.9b | 20.9x | 34.3x | 5.4x |
| Mon, 21 Apr 2025 | AU$129.6b | AU$24.9b | AU$3.9b | 20.4x | 32.9x | 5.2x |
| Wed, 19 Mar 2025 | AU$134.7b | AU$25.0b | AU$4.0b | 21.4x | 34.1x | 5.4x |
| Fri, 14 Feb 2025 | AU$139.5b | AU$25.2b | AU$3.8b | 22.7x | 36.3x | 5.5x |
| Sun, 12 Jan 2025 | AU$153.0b | AU$25.0b | AU$3.7b | 24.1x | 40.8x | 6.1x |
| Tue, 10 Dec 2024 | AU$150.1b | AU$23.9b | AU$3.6b | 25.3x | 42.2x | 6.3x |
| Thu, 07 Nov 2024 | AU$151.2b | AU$23.5b | AU$3.5b | 26.8x | 43.3x | 6.4x |
| Sat, 05 Oct 2024 | AU$152.1b | AU$22.5b | AU$3.3b | 28x | 45.7x | 6.8x |
| Mon, 02 Sep 2024 | AU$159.3b | AU$22.8b | AU$3.5b | 30x | 45.3x | 7x |
| Wed, 31 Jul 2024 | AU$160.6b | AU$22.5b | AU$3.3b | 31.9x | 48.5x | 7.1x |
| Fri, 28 Jun 2024 | AU$153.5b | AU$22.1b | AU$3.2b | 31.9x | 47.3x | 6.9x |
| Sun, 26 May 2024 | AU$145.8b | AU$22.2b | AU$3.2b | 31.1x | 45x | 6.6x |
| Tue, 23 Apr 2024 | AU$138.9b | AU$22.9b | AU$3.4b | 28.9x | 41.3x | 6.1x |
| Thu, 21 Mar 2024 | AU$142.6b | AU$22.5b | AU$3.3b | 29.1x | 43.2x | 6.3x |
| Sat, 17 Feb 2024 | AU$144.5b | AU$22.3b | AU$3.3b | 31x | 44x | 6.5x |
| Mon, 15 Jan 2024 | AU$147.8b | AU$20.5b | AU$2.7b | 34.6x | 54.4x | 7.2x |
| Wed, 13 Dec 2023 | AU$137.1b | AU$20.8b | AU$2.8b | 33.5x | 49.6x | 6.6x |
| Fri, 10 Nov 2023 | AU$128.7b | AU$21.4b | AU$2.9b | 30.8x | 44.9x | 6x |
| Sun, 08 Oct 2023 | AU$128.1b | AU$21.5b | AU$2.8b | 29.7x | 45.4x | 6x |
| Tue, 05 Sep 2023 | AU$137.1b | AU$21.3b | AU$2.8b | 33.7x | 49.3x | 6.5x |
| Thu, 03 Aug 2023 | AU$138.3b | AU$18.3b | AU$2.4b | 36.6x | 58.5x | 7.6x |
| Sat, 01 Jul 2023 | AU$142.7b | AU$18.2b | AU$2.4b | 37.7x | 60.7x | 7.9x |
| Mon, 29 May 2023 | AU$155.7b | AU$18.4b | AU$2.4b | 39.9x | 65x | 8.5x |
| Wed, 26 Apr 2023 | AU$155.7b | AU$18.1b | AU$2.3b | 42x | 66.4x | 8.6x |
| Fri, 24 Mar 2023 | AU$146.8b | AU$17.9b | AU$2.3b | 39.6x | 63.6x | 8.2x |
| Sun, 19 Feb 2023 | AU$151.9b | AU$17.3b | AU$2.3b | 51.3x | 66.5x | 8.8x |
| Tue, 17 Jan 2023 | AU$146.7b | AU$15.5b | AU$2.4b | 50.9x | 60x | 9.5x |
| Thu, 15 Dec 2022 | AU$152.8b | AU$15.7b | AU$2.5b | 47.4x | 61.3x | 9.7x |
| Sat, 12 Nov 2022 | AU$149.4b | AU$16.3b | AU$2.6b | 45x | 57.3x | 9.1x |
| Mon, 10 Oct 2022 | AU$147.2b | AU$16.8b | AU$2.7b | 42.6x | 54.5x | 8.8x |
| Wed, 07 Sep 2022 | AU$149.5b | AU$15.8b | AU$2.5b | 44.6x | 59.4x | 9.5x |
| Fri, 05 Aug 2022 | AU$150.1b | AU$15.6b | AU$2.8b | 41.1x | 53.4x | 9.6x |
| Sun, 03 Jul 2022 | AU$135.9b | AU$15.9b | AU$2.9b | 34.5x | 47.3x | 8.6x |
| Tue, 31 May 2022 | AU$138.8b | AU$15.1b | AU$2.7b | 37x | 51.2x | 9.2x |
Price to Earnings Ratio
51.2x
Current Industry PE
- Investors are pessimistic on the Australian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 34.1x which is lower than its 3-year average PE of 50.3x.
- The 3-year average PS ratio of 7.4x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have grown 13% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Australian Biotech compare with similar industries?
| AU Market | 0.14% | |
| Healthcare | 0.95% | |
| Biotech | 1.45% | |
| Biotech | 1.45% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CSL CSL | AU$246.38 | 1.9% +AU$2.2b | -12.3% | PE28.1x | |
| DXB Dimerix | AU$0.61 | 2.5% +AU$10.1m | 79.4% | PS480.3x | |
| ARX Aroa Biosurgery | AU$0.45 | 2.3% +AU$3.4m | -8.2% | PS2.2x | |
| OCC Orthocell | AU$1.29 | 0.8% +AU$2.4m | 238.2% | PS49.2x | |
| COV Cleo Diagnostics | AU$0.38 | 4.2% +AU$1.9m | 120.6% | PS228.6x |
